Login / Signup

Smoking and cardiovascular disease in patients with type 2 diabetes: a prospective observational study.

Peder Af GeijerstamFredrik JanrydFredrik H Nystrom
Published in: Journal of cardiovascular medicine (Hagerstown, Md.) (2023)
In patients with T2D, cigarette smoking was not associated with an increased risk of MACE. This raises the question of whether cardioprotective drugs in individuals with T2D to some degree mitigate the cardiovascular harm of smoking, even though they do not affect other dire consequences of smoking.
Keyphrases
  • smoking cessation
  • cardiovascular disease
  • type diabetes
  • metabolic syndrome
  • cardiovascular risk factors
  • drug induced